Adriano Fontana
Adriano Fontana
Professor emeritus in Immunology, University of Zurich
No verified email
TitleCited byYear
Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape
M Hahne, D Rimoldi, M Schröter, P Romero, M Schreier, LE French, ...
Science 274 (5291), 1363-1366, 1996
Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells.
A Fontana, F Kristensen, R Dubs, D Gemsa, E Weber
The Journal of Immunology 129 (6), 2413-2419, 1982
Astrocytes present myelin basic protein to encephalitogenic T-cell lines
A Fontana, W Fierz, H Wekerle
Nature 307 (5948), 273, 1984
RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
L Codarri, G Gyülvészi, V Tosevski, L Hesske, A Fontana, L Magnenat, ...
Nature immunology 12 (6), 560, 2011
Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity
P Schneider, N Holler, JL Bodmer, M Hahne, K Frei, A Fontana, ...
Journal of Experimental Medicine 187 (8), 1205-1213, 1998
On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases
K Frei, UV Malipiero, TP Leist, RM Zinkernagel, ME Schwab, A Fontana
European journal of immunology 19 (4), 689-694, 1989
Antigen presentation and tumor cytotoxicity by interferon‐γ‐treated microglial cells
K Frei, C Siepl, P Groscurth, S Bodmer, C Schwerdel, A Fontana
European journal of immunology 17 (9), 1271-1278, 1987
Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice
HT Lau, M Yu, A Fontana, CJ Stoeckert
Science 273 (5271), 109-112, 1996
Increased number of islet-associated macrophages in type 2 diabetes
JA Ehses, A Perren, E Eppler, P Ribaux, JA Pospisilik, R Maor-Cahn, ...
Diabetes 56 (9), 2356-2370, 2007
Astrocytes as antigen-presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation.
W Fierz, B Endler, K Reske, H Wekerle, A Fontana
The Journal of Immunology 134 (6), 3785-3793, 1985
Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate
D Piani, K Frei, KQ Do, M Cuénod, A Fontana
Neuroscience letters 133 (2), 159-162, 1991
Glucose induces β-cell apoptosis via upregulation of the Fas receptor in human islets
K Maedler, GA Spinas, R Lehmann, P Sergeev, M Weber, A Fontana, ...
Diabetes 50 (8), 1683-1690, 2001
Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.
S Bodmer, K Strommer, K Frei, C Siepl, N De Tribolet, I Heid, A Fontana
The Journal of Immunology 143 (10), 3222-3229, 1989
Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.
A Fontana, H Hengartner, N De Tribolet, E Weber
The Journal of Immunology 132 (4), 1837-1844, 1984
Complementary DNA for human glioblastoma‐derived T cell suppressor factor, a novel member of the transforming growth factor‐beta gene family.
R De Martin, B Haendler, R Hofer‐Warbinek, H Gaugitsch, M Wrann, ...
The EMBO journal 6 (12), 3673-3677, 1987
Differential expression of transforming growth factor-beta 1,-beta 2, and-beta 3 by glioblastoma cells, astrocytes, and microglia.
DB Constam, J Philipp, UV Malipiero, P Ten Dijke, M Schachner, ...
The Journal of Immunology 148 (5), 1404-1410, 1992
Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.
M Weller, K Frei, P Groscurth, PH Krammer, Y Yonekawa, A Fontana
The Journal of clinical investigation 94 (3), 954-964, 1994
The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis
N Sommer, PA Löschmann, GH Northoff, M Weller, A Steinbrecher, ...
Nature medicine 1 (3), 244, 1995
T cell suppressor factor from human glioblastoma cells is a 12.5‐kd protein closely related to transforming growth factor‐beta.
M Wrann, S Bodmer, R De Martin, C Siepl, R Hofer‐Warbinek, K Frei, ...
The EMBO journal 6 (6), 1633-1636, 1987
Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis
A Fontana, H Hengartner, E Weber, K Fehr, PJ Grob, G Cohen
Rheumatology international 2 (2), 49-53, 1982
The system can't perform the operation now. Try again later.
Articles 1–20